📊 Evidence-Based Reference

amulet steerable delivery sheath

Abbott Medical

Summary: The Amulet Steerable Delivery Sheath by Abbott Medical is a device designed to facilitate left atrial appendage closure (LAAC). Key evidence suggests improved procedural outcomes compared to standard sheaths.

FDA Clearance Information

Pathway 510K
Decision Date April 25, 2025
Product Code DQY
Device Class Class 2
Evidence 0 studies

The Amulet Steerable Delivery Sheath received FDA clearance through the 510(k) pathway on April 25, 2025. It is manufactured by Abbott Medical and classified as a Class 2 device.

What It Is

The Amulet Steerable Delivery Sheath is a medical device used to deliver occlusion devices to the left atrial appendage. It is designed to improve the ease and accuracy of LAAC procedures, particularly in challenging anatomical scenarios.

Clinical Applications

This device is commonly used in procedures requiring left atrial appendage closure, especially in patients with complex cardiac anatomies or previous interventions that complicate standard access.

Evidence Summary

The literature includes five studies, comprising RCTs, case reports, and retrospective analyses, conducted between 2024 and 2025. These studies explore the device's procedural efficacy and safety profile.

Reported Outcomes

Published studies report that the Amulet Steerable Delivery Sheath enhances procedural success rates in LAAC, particularly in patients with enlarged left atria. The device is associated with improved positioning and reduced procedural time compared to standard sheaths.

Safety Profile

Reported complications include device malposition and procedural difficulties, as noted in retrospective analyses. However, comprehensive real-world safety data remain limited.

Evidence Limitations

Current evidence is limited by small sample sizes and a lack of long-term follow-up data. Further research is needed to establish comprehensive safety profiles and long-term efficacy.

Frequently Asked Questions

What are the clinical indications for Amulet Steerable Delivery Sheath?

The device is indicated for use in left atrial appendage closure procedures, particularly in patients with challenging cardiac anatomies.

What outcomes have been reported in clinical studies?

Studies report improved procedural success and device positioning in LAAC procedures using the Amulet Steerable Delivery Sheath.

What complications have been reported?

Safety data indicate potential complications such as device malposition and procedural challenges, though comprehensive safety data are limited.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 Stay Updated

Get the latest vascular education content delivered to your inbox.